285 related articles for article (PubMed ID: 21448240)
21. Complexation of fungal extracellular nucleic acids by host LL-37 peptide shapes neutrophil response to
Juszczak M; Zawrotniak M; Rapala-Kozik M
Front Immunol; 2024; 15():1295168. PubMed ID: 38384468
[No Abstract] [Full Text] [Related]
22. Combined effect of lasioglossin LL-III derivative with azoles against Candida albicans virulence factors: biofilm formation, phospholipases, proteases and hemolytic activity.
Vaňková E; Kašparová P; Dulíčková N; Čeřovský V
FEMS Yeast Res; 2020 May; 20(3):. PubMed ID: 32324227
[TBL] [Abstract][Full Text] [Related]
23. Antimicrobial and immunomodulatory activity of host defense peptides, clavanins and LL-37, in vitro: An endodontic perspective.
Lima SMF; Freire MS; Gomes ALO; Cantuária APC; Dutra FRP; Magalhães BS; Sousa MGC; Migliolo L; Almeida JA; Franco OL; Rezende TMB
Peptides; 2017 Sep; 95():16-24. PubMed ID: 28712894
[TBL] [Abstract][Full Text] [Related]
24. Candida albicans mucin Msb2 is a broad-range protectant against antimicrobial peptides.
Swidergall M; Ernst AM; Ernst JF
Antimicrob Agents Chemother; 2013 Aug; 57(8):3917-22. PubMed ID: 23733470
[TBL] [Abstract][Full Text] [Related]
25. Structure-function relationships among human cathelicidin peptides: dissociation of antimicrobial properties from host immunostimulatory activities.
Braff MH; Hawkins MA; Di Nardo A; Lopez-Garcia B; Howell MD; Wong C; Lin K; Streib JE; Dorschner R; Leung DY; Gallo RL
J Immunol; 2005 Apr; 174(7):4271-8. PubMed ID: 15778390
[TBL] [Abstract][Full Text] [Related]
26. [Demonstration of β-1,2 mannan structures expressed on the cell wall of Candida albicans yeast form but not on the hyphal form by using monoclonal antibodies].
Aydın C; Ataoğlu H
Mikrobiyol Bul; 2015 Jan; 49(1):66-76. PubMed ID: 25706732
[TBL] [Abstract][Full Text] [Related]
27. Remasking of Candida albicans β-Glucan in Response to Environmental pH Is Regulated by Quorum Sensing.
Cottier F; Sherrington S; Cockerill S; Del Olmo Toledo V; Kissane S; Tournu H; Orsini L; Palmer GE; Pérez JC; Hall RA
mBio; 2019 Oct; 10(5):. PubMed ID: 31615961
[No Abstract] [Full Text] [Related]
28. Antimicrobial Activities of LL-37 Fragment Mutant-Poly (Lactic-Co-Glycolic) Acid Conjugate against
Mori T; Yoshida M; Hazekawa M; Ishibashi D; Hatanaka Y; Nagao T; Kakehashi R; Kojima H; Uno R; Ozeki M; Kawasaki I; Yamashita T; Nishikawa J; Uchida T
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065861
[TBL] [Abstract][Full Text] [Related]
29. Human corneal epithelial cells produce antimicrobial peptides LL-37 and β-defensins in response to heat-killed Candida albicans.
Hua X; Yuan X; Tang X; Li Z; Pflugfelder SC; Li DQ
Ophthalmic Res; 2014; 51(4):179-86. PubMed ID: 24662332
[TBL] [Abstract][Full Text] [Related]
30. Effects of the binding of a Helianthus annuus lectin to Candida albicans cell wall on biofilm development and adhesion to host cells.
Del Rio M; de la Canal L; Pinedo M; Mora-Montes HM; Regente M
Phytomedicine; 2019 May; 58():152875. PubMed ID: 30884454
[TBL] [Abstract][Full Text] [Related]
31. Molecular determinants of the interaction between human high molecular weight kininogen and Candida albicans cell wall: Identification of kininogen-binding proteins on fungal cell wall and mapping the cell wall-binding regions on kininogen molecule.
Karkowska-Kuleta J; Kedracka-Krok S; Rapala-Kozik M; Kamysz W; Bielinska S; Karafova A; Kozik A
Peptides; 2011 Dec; 32(12):2488-96. PubMed ID: 22074954
[TBL] [Abstract][Full Text] [Related]
32. Dynamic, morphotype-specific Candida albicans beta-glucan exposure during infection and drug treatment.
Wheeler RT; Kombe D; Agarwala SD; Fink GR
PLoS Pathog; 2008 Dec; 4(12):e1000227. PubMed ID: 19057660
[TBL] [Abstract][Full Text] [Related]
33. Effect of monoclonal antibodies directed against Candida albicans cell wall antigens on the adhesion of the fungus to polystyrene.
San Millan R; Ezkurra PA; Quindós G; Robert R; Senet JM; Pontón J
Microbiology (Reading); 1996 Aug; 142 ( Pt 8)():2271-7. PubMed ID: 8760939
[TBL] [Abstract][Full Text] [Related]
34. Loss of mannosylphosphate from Candida albicans cell wall proteins results in enhanced resistance to the inhibitory effect of a cationic antimicrobial peptide via reduced peptide binding to the cell surface.
Harris M; Mora-Montes HM; Gow NAR; Coote PJ
Microbiology (Reading); 2009 Apr; 155(Pt 4):1058-1070. PubMed ID: 19332808
[TBL] [Abstract][Full Text] [Related]
35. Activation of HIF-1α and LL-37 by commensal bacteria inhibits Candida albicans colonization.
Fan D; Coughlin LA; Neubauer MM; Kim J; Kim MS; Zhan X; Simms-Waldrip TR; Xie Y; Hooper LV; Koh AY
Nat Med; 2015 Jul; 21(7):808-14. PubMed ID: 26053625
[TBL] [Abstract][Full Text] [Related]
36. Antimicrobial and chemoattractant activity, lipopolysaccharide neutralization, cytotoxicity, and inhibition by serum of analogs of human cathelicidin LL-37.
Ciornei CD; Sigurdardóttir T; Schmidtchen A; Bodelsson M
Antimicrob Agents Chemother; 2005 Jul; 49(7):2845-50. PubMed ID: 15980359
[TBL] [Abstract][Full Text] [Related]
37. Face/Off: The Interchangeable Side of
Cottier F; Hall RA
Front Cell Infect Microbiol; 2019; 9():471. PubMed ID: 32047726
[TBL] [Abstract][Full Text] [Related]
38. Targeting adhesion in fungal pathogen
Martin H; Kavanagh K; Velasco-Torrijos T
Future Med Chem; 2021 Feb; 13(3):313-334. PubMed ID: 32564615
[TBL] [Abstract][Full Text] [Related]
39. The human cathelicidin hCAP18/LL-37: a multifunctional peptide involved in mycobacterial infections.
Méndez-Samperio P
Peptides; 2010 Sep; 31(9):1791-8. PubMed ID: 20600427
[TBL] [Abstract][Full Text] [Related]
40. Candidacidal Activity of Selected Ceragenins and Human Cathelicidin LL-37 in Experimental Settings Mimicking Infection Sites.
Durnaś B; Wnorowska U; Pogoda K; Deptuła P; Wątek M; Piktel E; Głuszek S; Gu X; Savage PB; Niemirowicz K; Bucki R
PLoS One; 2016; 11(6):e0157242. PubMed ID: 27315208
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
